BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14764534)

  • 1. Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation.
    Samson SI; Mémet S; Vosshenrich CA; Colucci F; Richard O; Ndiaye D; Israël A; Di Santo JP
    Blood; 2004 Jun; 103(12):4573-80. PubMed ID: 14764534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival.
    Goudeau B; Huetz F; Samson S; Di Santo JP; Cumano A; Beg A; Israël A; Mémet S
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15800-5. PubMed ID: 14665694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in I kappa B epsilon and changes in NF-kappa B activity during B lymphocyte differentiation.
    Doerre S; Mesires KP; Daley KM; McCarty T; Knoetig S; Corley RB
    J Immunol; 2005 Jan; 174(2):983-91. PubMed ID: 15634922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes.
    Stanic AK; Bezbradica JS; Park JJ; Matsuki N; Mora AL; Van Kaer L; Boothby MR; Joyce S
    J Immunol; 2004 Feb; 172(4):2265-73. PubMed ID: 14764695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response.
    Corn RA; Aronica MA; Zhang F; Tong Y; Stanley SA; Kim SR; Stephenson L; Enerson B; McCarthy S; Mora A; Boothby M
    J Immunol; 2003 Aug; 171(4):1816-24. PubMed ID: 12902482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IkappaBepsilon-deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis.
    Mémet S; Laouini D; Epinat JC; Whiteside ST; Goudeau B; Philpott D; Kayal S; Sansonetti PJ; Berche P; Kanellopoulos J; Israël A
    J Immunol; 1999 Dec; 163(11):5994-6005. PubMed ID: 10570287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii.
    Tato CM; Villarino A; Caamaño JH; Boothby M; Hunter CA
    J Immunol; 2003 Mar; 170(6):3139-46. PubMed ID: 12626571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and functional characterization of mouse IkappaBepsilon.
    Simeonidis S; Liang S; Chen G; Thanos D
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14372-7. PubMed ID: 9405619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma.
    Tato CM; Mason N; Artis D; Shapira S; Caamano JC; Bream JH; Liou HC; Hunter CA
    Int Immunol; 2006 Apr; 18(4):505-13. PubMed ID: 16481345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.
    Tergaonkar V; Correa RG; Ikawa M; Verma IM
    Nat Cell Biol; 2005 Sep; 7(9):921-3. PubMed ID: 16136188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.
    Zuckerbraun BS; McCloskey CA; Mahidhara RS; Kim PK; Taylor BS; Tzeng E
    J Vasc Surg; 2003 Oct; 38(4):812-9. PubMed ID: 14560235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency.
    McDonald DR; Mooster JL; Reddy M; Bawle E; Secord E; Geha RS
    J Allergy Clin Immunol; 2007 Oct; 120(4):900-7. PubMed ID: 17931563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
    Caamaño J; Tato C; Cai G; Villegas EN; Speirs K; Craig L; Alexander J; Hunter CA
    J Immunol; 2000 Nov; 165(10):5720-8. PubMed ID: 11067930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
    Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
    Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
    Finn PW; He H; Ma C; Mueller T; Stone JR; Liou HC; Boothby MR; Perkins DL
    J Leukoc Biol; 2002 Nov; 72(5):1054-62. PubMed ID: 12429729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nuclear factor kappaB inhibition on tumor cell sensitivity to natural killer-mediated cytolytic function.
    Mami-Chouaib F; Ameyar M; Dorothée G; Bentires-Alj M; Dziembowska M; Delhalle S; Gay F; Stancou R; Bours V; Chouaib S
    Eur J Immunol; 2001 Feb; 31(2):433-9. PubMed ID: 11180107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation.
    Fan C; Li Q; Zhang Y; Liu X; Luo M; Abbott D; Zhou W; Engelhardt JF
    J Clin Invest; 2004 Mar; 113(5):746-55. PubMed ID: 14991073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia.
    Zhang Y; Ting AT; Marcu KB; Bliska JB
    J Immunol; 2005 Jun; 174(12):7939-49. PubMed ID: 15944300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
    Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
    Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner.
    Alves BN; Tsui R; Almaden J; Shokhirev MN; Davis-Turak J; Fujimoto J; Birnbaum H; Ponomarenko J; Hoffmann A
    J Immunol; 2014 Apr; 192(7):3121-32. PubMed ID: 24591377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.